Cymabay Therapeutics - Ownership and Business Overview

Life ScienceCompany

Cymabay Therapeutics Ownership

Who owns Cymabay Therapeutics?

Cymabay Therapeutics is owned by Gilead Sciences. It was acquired on February 12, 2024.

Was Cymabay Therapeutics formerly PE-backed?

Yes. Cymabay Therapeutics was formerly owned by 3 private investors.

Cymabay Therapeutics Business Overview

Where is Cymabay Therapeutics headquartered?

Cymabay Therapeutics is headquartered in Newark, California.

What is Cymabay Therapeutics’ revenue?

Cymabay Therapeutics disclosed revenue of 10M USD for 2017 and 3M USD for 2012.

What sector is Cymabay Therapeutics in?

Cymabay Therapeutics is a life science company.

When was Cymabay Therapeutics founded?

Cymabay Therapeutics was founded in 1988.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.

Cymabay Therapeutics

Cymabay Therapeutics, Inc.

7575 Gateway Boulevard, Suite 110,
Newark, California 94560
United States,
(510) 293-8800
www.cymabay.com

Cymabay Therapeutics is a clinical-stage bio-pharmaceutical company developing breakthrough therapies addressing unmet medical needs. Cymabay Therapeutics was founded in 1988 and is based in Newark, California.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.